Ribomunyl
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background Upper respiratory tract infection is a frequent cause of morbidity worldwide. Although the course of infection is…
Ribomunyl is an immunostimulant that was developed and commercialized in the 1980s in France and has subsequently been made…
OBJECTIVE
To study the effects of ribomunyl, an oral ribosomal immunostimulant frequently used to prevent recurrent oropharyngeal…
Dendritic cells (DC) are essential for the generation of primary adaptive immune responses, but their full immunostimulatory…
Ribomunyl, an immunomodulating agent, administered to mice 24 h before irradiation, has a radioprotective effect. Ribomunyl…
Alveolar macrophages (AMs) may play a key role in human respiratory immune defenses, partially by synthesizing and releasing…
We reported one observation of a female patient who presented an half delayed hypersensitivity reaction to formaldehyde included…